Needle-Free Alternative: First Epinephrine Nasal Spray Clears FDA
A committee of FDA outside advisers voted last week in favor of an epinephrine nasal spray product, clearing a key hurdle for what could soon be the first needle-free option for treating severe allergic reactions. ARS Pharmaceuticals proposed epinephrine spray, branded as Neffy, that is designed to deliver a 2 milligram dose of epinephrine, which can reverse the symptoms of a life-threatening allergic reaction. The company is seeking the FDA's approval for anyone weighing at least 30 kilograms — around 66 pounds — and is working on future studies for smaller children. Read more from CBS News here.